Living with arthritis or ankylosing spondylitis can be a challenge, and finding the right medication is a critical step. However, some patients develop serious skin reactions, known as SCARs, when taking the drug sulfasalazine. These reactions can be severe and dangerous, making it vital for doctors to know who is at risk before a prescription is even written.
Researchers looked at data from patients across four Asian countries, including China, Taiwan, Japan, Thailand, and Malaysia. They found that specific genetic markers, called HLA-B alleles, are strongly linked to these dangerous skin reactions. In one group, these markers showed about 85% sensitivity in predicting a reaction in the Chinese population. The study also found that the drug can trigger a specific immune response in the cells of affected patients.
While these genetic markers provide a clearer way to identify who might be at risk, it is important to remember that the markers show a link, not a guaranteed cause. The study confirms these associations across multiple countries, offering a clearer picture for doctors and patients. Always talk to your doctor about your specific medical history and any concerns regarding new medications.
